Esomeprazole 40 mg intravenous provides faster and more effective acid control than pantoprazole 40 mg intravenous after first dose and 5 days

Wilder-Smith, C; Bondarov, P; Hallerbäck, B; Nilsson-Pieschl, C; Ahlbom, H; Röhss, K
September 2003
American Journal of Gastroenterology;Sep2003 Supplement, Vol. 98, pS24
Academic Journal
An abstract of the article "Esomeprazole 40 mg Intravenous Provides Faster and More Effective Acid Control Than Pantoprazole 40 mg Intravenous After First Dose and 5 Days," by C. Wilder-Smith, P. Bondarov, B. Hallerbäck, C. Nilsson-Pieschl, H. Ahlbom, and K. Röhss is presented.


Related Articles

  • Esomeprazole as maintenance therapy in erosive esophagitis: a quantitative assessment of efficacy using an evidence-based approach. Johnson, David A; Hoyle, Paul E; Traxler, Barry M; Levine, Douglas; Lauritsen, Karsten // American Journal of Gastroenterology;Sep2003 Supplement, Vol. 98, pS34 

    An abstract of the article "Esomeprazole As Maintenance Therapy in Erosive Esophagitis: A Quantitative Assessment of Efficacy Using an Evidence-based Approach," by David A. Johnson, Paul E. Hoyle, Barry M. Traxler, Douglas Levine and Karsten Lauritsen is presented.

  • Esomeprazole 20 mg administered as a 30-minute infusion provides a similar level of acid control as oral administration in healthy subjects. Wilder-Smith, C H; Nilsson-Pieschl, C; Lundgren, M; Ahlbom, H; Röhss, K // American Journal of Gastroenterology;Sep2003 Supplement, Vol. 98, pS21 

    An abstract of the article "Esomeprazole 20 mg Administered As a 30-minute Infusion Provides a Similar Level of Acid Control as Oral Administration in Healthy Subjects," by C. H. Wilder-Smith, C. Nilsson-Pieschl, M. Lundgren, H. Ahlbom, and K. Röhss is presented.

  • The influence of demographic factors and health-related quality of life on treatment satisfaction in patients with gastroesophageal reflux disease treated with esomeprazole. Innocenti, Alessio Degl'; Guyatt, Gordon H.; Wiklund, Ingela; Heels-Ansdell, Diane; Armstrong, David; Fallone, Carlo A.; Tanser, Lisa; Van Zanten, Sander Veldhuyzen; El-Dika, Samer; Chiba, Naoki; Barkun, Alan N.; Austin, Peggy; Schünemann, Holger J. // Health & Quality of Life Outcomes;2005, Vol. 3, p4 

    Background: The correlation between treatment satisfaction and demographic characteristics, symptoms, or healthrelated quality of life (HRQL) in patients with gastroesophageal reflux disease (GERD) is unknown. The objective of this study was to assess correlates of treatment satisfaction in...

  • Antisecretory for esophagitis.  // Modern Medicine;Jun96, Vol. 64 Issue 6, p41 

    Reports on a drug called lansoprazole indicated for the treatment of erosive esophagitis, a condition characterized by gastroesophageal reflux and stomach contents which erode the mucosal lining of the esophageal tract. Lansoprazole as a proton-pump inhibitor; Recommended dosage.

  • Healed erosive esophagitis.  // Modern Medicine;Jan95, Vol. 63 Issue 1, p29 

    Reports on the use of ranitidine HCl, as Zantac from Glaxo Pharmaceutical, for the maintenance of healed erosive esophagitis. Suggested dosage; Other approved indications for the drug.

  • Medical therapy is effective--and cost-effective--for esophagitis.  // Modern Medicine;Jul97, Vol. 65 Issue 7, p57 

    Presents an abstract of the study `Choice of long-term strategy for the management of patients with severe esophagitis: A cost-utility analysis,' by G.R. Heudebert, R. Marks, C.M. Wilcox et al published in the April 1997 issue of `Gastroenterology' journal.

  • Expert panel rates GERD drugs. Liebman, Milton // Medical Marketing & Media;Dec2002, Vol. 37 Issue 12, p6 

    Examines the efficacy of over-the-counter drugs and prescription drugs for the treatment of gastroesophageal diseases in the U.S. Details on the healing actions of standard doses of proton pump inhibitors; Ability of OTC drugs to relieve heartburn and esophagitis; Use of antacids for the relief...

  • Esomeprazole: A Review of its Use in the Management of Acid-Related Disorders in the US. Scott, L.J.; Dunn, C.J.; Mallarkey, G.; Sharpe, M. // Drugs;2002, Vol. 62 Issue 7, p1091 

    Esomeprazole, the S-isomer of omeprazole, is the first proton pump inhibitor to be developed as a single optical isomer. It provides better acid control than current racemic proton pump inhibitors and has a favourable pharmacokinetic profile relative to omeprazole. In large well designed 8-week...

  • Cimetidine and metoclopramide in oesophageal reflux disease. Temple, J.G.; Bradby, G.V.H.; O'Connor, F.; Panesar, K.S.; Mulligan, T.O.; Robinson, T.J.; Ward, D.W. // British Medical Journal (Clinical Research Edition);6/11/1983, Vol. 286 Issue 6381, p1863 

    Examines the effectiveness of cimetidine and metoclopramide treatments in oesophageal reflux disease. Symptomatic and endoscopic assessment of the patients with the reflux disease; Reasons for withdrawal of the patients in the combination treatment group; Analysis of the endoscopic appearance...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics